Gorinchem, Netherlands
Gorinchem, Netherlands

Time filter

Source Type

Huyskens C.,Institute for Sustainable Process Technology ISPT | Huyskens C.,Flemish Institute for Technological Research | Helsen J.,Flemish Institute for Technological Research | Groot W.J.,Corbion Purac | And 2 more authors.
Separation and Purification Technology | Year: 2015

The bio-based industry is striving to replace refined sugars by much cheaper secondary feedstocks for the production of bio-fuels and chemicals. However, due to their higher complexity, a number of technological challenges need to be overcome. One example are the high concentrations of sodium and potassium present in the biomass hydrolysates that inhibit fermentation and hence need to be reduced. Previous research demonstrated the technical feasibility of membrane capacitive deionization (MCDI) for biomass hydrolysate desalination as a chemical/waste free alternative compared to the commonly used ion-exchange process (IEX). In this paper, the economic viability of MCDI was investigated for a production capacity of 500 ton sugar day-1 and a target Na removal from 3 to 0.1 g kg-1 hydrolysate. Although capital costs were higher for MCDI than for IEX due to the expensive MCDI cells and power supplies, operating costs were lower because less water and chemicals are used and less wastewater is generated. Cost calculations for different initial feed concentrations indicated that IEX was only preferential over MCDI when the feed Na+ concentration was below 0.4 g kg-1 hydrolysate. Then the higher chemical, water and wastewater treatment costs for IEX no longer outweighed the higher cost of MCDI cells compared to IEX resins. © 2015 Elsevier B.V. All rights reserved.


News Article | November 16, 2016
Site: www.newsmaker.com.au

Polycaprolactone is a specialty building block in high-performance polyurethane elastomer. Owing to its value-added properties such as molecular weight distribution, hydrophobicity, and low viscosity, polycaprolactone and its copolymers such as polycaprolactonediol, polycaprolactonetriol, and polycaprolactonetetral has found wide application in the production of polyurethane (PU), thermoplastic polyurethane (TPU), and polyols. Polycaprolactone-based polyurethanes are widely used in coatings, adhesive, sealants and elastomers. Due to its high permeability, PCL can form compatible blends with other bio-based polymers, which can improve the degradation kinetics, stress & crack resistance, dyeability, and control over the release rate of drugs. Hence, it is used for manufacturing of medical devices and components. PCL is generally blended with PGA or PLA. However, different blends of PCL result in different serviceability and properties of the blended material. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/polycaprolactone-market/toc According to a recent market report published by Persistence Market Research titled “Global Market Study on Polycaprolactone: Demand for Environment-Friendly Packaging Materials, Catalyzed the Polycaprolactone Market ”, the global polycaprolactone market has been estimated to reach value of US$ 113.9 Mn by end of 2015, and is expected to expand at a CAGR of 11.1% between 2015 and 2021. Growing demand for environment-friendly packaging materials leads to the development of a number of new biopolymers that have shown the ability to degrade naturally in the environment. PCL has the ability to blend with natural polymers, and its blend is commercially used for manufacturing of plastic films and bags. This is expected to emerge as a factor driving the growth of the polycaprolactone market during the forecast period. Continuous research for application of PCL in the biomedical sector, focused on eco-friendly and cost efficient solutions and increasing consumption of polyurethane in developing economies, are other factors expected to fuel the growth of the market over the forecast period. However, availability of substitutes at cheaper costs and volatility of raw material costs are likely to impede the growth of the global polycaprolactone market during the forecast period. Global polycaprolactone consumption is expected to increase from 58,151.8 metric tons over 2015 to 105,122.6 metric tons by 2021, expanding at a CAGR of 10.4% during the forecast period. In terms of market value, Europe is expected to dominate the global polycaprolactone market over the forecast period, with Asia Pacific being the second largest market, accounting for revenue share of 28.6% of the global estimated market value by 2015 end. Europe polycaprolactone market is slated to expand at the highest CAGR of around 10.5% in terms of value between 2015 and 2021. On the basis of application, the healthcare segment is expected to expand at the fastest CAGR in terms of value during the forecast period. Growth of this segment is primarily driven by increased adoption of polycaprolactone in manufacturing of drug delivery devices. Drug delivery and wound care management segments are expected to witness growth of 11.1% and 11.4% in terms of consumption during the forecast period. On the basis of form type, revenue from pellets segment is expected expand at a CAGR of 11.0% during the forecast period. Perstorp Holding A.B., BASF SE, and Diacel Corporation are the leading players in the global polycaprolactone market. Other players include Durect Corporation, Corbion Purac, Sigma-Aldrich Corporation, and Shenzhen Esun Industries Co. Ltd.


News Article | November 29, 2016
Site: www.newsmaker.com.au

The global polycaprolactone market has been estimated to reach value of US$ 113.9 Mn by end of 2015, and is expected to expand at a CAGR of 11.1% between 2015 and 2021. Polycaprolactone is a specialty building block in high-performance polyurethane elastomer. Owing to its value-added properties such as molecular weight distribution, hydrophobicity, and low viscosity, polycaprolactone and its copolymers such as polycaprolactonediol, polycaprolactonetriol, and polycaprolactonetetral has found wide application in the production of polyurethane (PU), thermoplastic polyurethane (TPU), and polyols. Polycaprolactone-based polyurethanes are widely used in coatings, adhesive, sealants and elastomers. Due to its high permeability, PCL can form compatible blends with other bio-based polymers, which can improve the degradation kinetics, stress & crack resistance, dyeability, and control over the release rate of drugs. Hence, it is used for manufacturing of medical devices and components. PCL is generally blended with PGA or PLA. However, different blends of PCL result in different serviceability and properties of the blended material. Growing demand for environment-friendly packaging materials leads to the development of a number of new biopolymers that have shown the ability to degrade naturally in the environment. PCL has the ability to blend with natural polymers, and its blend is commercially used for manufacturing of plastic films and bags. This is expected to emerge as a factor driving the growth of the polycaprolactone market during the forecast period. Continuous research for application of PCL in the biomedical sector, focused on eco-friendly and cost efficient solutions and increasing consumption of polyurethane in developing economies, are other factors expected to fuel the growth of the market over the forecast period. However, availability of substitutes at cheaper costs and volatility of raw material costs are likely to impede the growth of the global polycaprolactone market during the forecast period. Global polycaprolactone consumption is expected to increase from 58,151.8 metric tons over 2015 to 105,122.6 metric tons by 2021, expanding at a CAGR of 10.4% during the forecast period. In terms of market value, Europe is expected to dominate the global polycaprolactone market over the forecast period, with Asia Pacific being the second largest market, accounting for revenue share of 28.6% of the global estimated market value by 2015 end. Europe polycaprolactone market is slated to expand at the highest CAGR of around 10.5% in terms of value between 2015 and 2021. On the basis of application, the healthcare segment is expected to expand at the fastest CAGR in terms of value during the forecast period. Growth of this segment is primarily driven by increased adoption of polycaprolactone in manufacturing of drug delivery devices. Drug delivery and wound care management segments are expected to witness growth of 11.1% and 11.4% in terms of consumption during the forecast period. On the basis of form type, revenue from pellets segment is expected expand at a CAGR of 11.0% during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/polycaprolactone-market/toc Perstorp Holding A.B., BASF SE, and Diacel Corporation are the leading players in the global polycaprolactone market. Other players include Durect Corporation, Corbion Purac, Sigma-Aldrich Corporation, and Shenzhen Esun Industries Co. Ltd.


News Article | November 24, 2016
Site: www.newsmaker.com.au

Polycaprolactone is a specialty building block in high-performance polyurethane elastomer. Owing to its value-added properties such as molecular weight distribution, hydrophobicity, and low viscosity, polycaprolactone and its copolymers such as polycaprolactonediol, polycaprolactonetriol, and polycaprolactonetetral has found wide application in the production of polyurethane (PU), thermoplastic polyurethane (TPU), and polyols. Polycaprolactone-based polyurethanes are widely used in coatings, adhesive, sealants and elastomers. Due to its high permeability, PCL can form compatible blends with other bio-based polymers, which can improve the degradation kinetics, stress & crack resistance, dyeability, and control over the release rate of drugs. Hence, it is used for manufacturing of medical devices and components. PCL is generally blended with PGA or PLA. However, different blends of PCL result in different serviceability and properties of the blended material. According to a recent market report published by Persistence Market Research titled “Global Market Study on Polycaprolactone: Demand for Environment-Friendly Packaging Materials, Catalyzed the Polycaprolactone Market ”, the global polycaprolactone market has been estimated to reach value of US$ 113.9 Mn by end of 2015, and is expected to expand at a CAGR of 11.1% between 2015 and 2021. Growing demand for environment-friendly packaging materials leads to the development of a number of new biopolymers that have shown the ability to degrade naturally in the environment. PCL has the ability to blend with natural polymers, and its blend is commercially used for manufacturing of plastic films and bags. This is expected to emerge as a factor driving the growth of the polycaprolactone market during the forecast period. Continuous research for application of PCL in the biomedical sector, focused on eco-friendly and cost efficient solutions and increasing consumption of polyurethane in developing economies, are other factors expected to fuel the growth of the market over the forecast period. However, availability of substitutes at cheaper costs and volatility of raw material costs are likely to impede the growth of the global polycaprolactone market during the forecast period. Global polycaprolactone consumption is expected to increase from 58,151.8 metric tons over 2015 to 105,122.6 metric tons by 2021, expanding at a CAGR of 10.4% during the forecast period. In terms of market value, Europe is expected to dominate the global polycaprolactone market over the forecast period, with Asia Pacific being the second largest market, accounting for revenue share of 28.6% of the global estimated market value by 2015 end. Europe polycaprolactone market is slated to expand at the highest CAGR of around 10.5% in terms of value between 2015 and 2021. On the basis of application, the healthcare segment is expected to expand at the fastest CAGR in terms of value during the forecast period. Growth of this segment is primarily driven by increased adoption of polycaprolactone in manufacturing of drug delivery devices. Drug delivery and wound care management segments are expected to witness growth of 11.1% and 11.4% in terms of consumption during the forecast period. On the basis of form type, revenue from pellets segment is expected expand at a CAGR of 11.0% during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/polycaprolactone-market/toc Perstorp Holding A.B., BASF SE, and Diacel Corporation are the leading players in the global polycaprolactone market. Other players include Durect Corporation, Corbion Purac, Sigma-Aldrich Corporation, and Shenzhen Esun Industries Co. Ltd.


Song Y.,CAS Beijing National Laboratory for Molecular | Zhang X.,Beijing Institute of Fashion Technology | Yin Y.,CAS Beijing National Laboratory for Molecular | Zhang C.,CAS Beijing National Laboratory for Molecular | And 5 more authors.
European Polymer Journal | Year: 2016

The isothermal crystallization behavior of a 1:1 poly(l-lactide)/poly(d-lactide) (PLLA/PDLA) mixture under pulsed shear was investigated by in-situ polarized light optical microscopy (POM) and wide angle X-ray scattering (WAXS). The effects of shear rate and temperature were studied. The results showed that application of shear flow increased the nucleation density, crystallization rate and degree of orientation for both stereocomplex crystals (SC) and α crystals. Interestingly, when the crystallization temperature was below the melting temperature of α crystals, the phase content of SC increased with shear rate, while the α content displayed a bell-shaped curve with regard to shear rate. The structure formation in this system was closely related to the shear-induced nucleation, phase mixing and chain mobility. © 2015 Elsevier Ltd. All rights reserved.


News Article | November 2, 2016
Site: marketersmedia.com

— Factors such as growing geriatric inhabitants worldwide, growing incidences of diseases and graft transplant surgeries, medical implants and technological advancements will drive the market growth. However, adverse reactions to biomaterials, strict regulatory requirements are some of the factors restraining the growth of global market. The cardiovascular segment is expected to account for the largest share among the applications. Metals constituted for the largest segment in 2015 and is growing at a strong CAGR during the forecast period. North America is expected to account for the largest share of the global biomaterials market, followed by Europe and Asia Pacific regions. Some of the key players in global Implantable Biomaterials market are AdvanSource Biomaterials Corporation, Collagen Matrix, Inc., Corbion Purac , Ceradyne, Inc, Celanese Corporation, Biomet, Inc., Evonik Industries AG, E. I. DU PONT DE Nemours And Company, Invibio, Inc., Orthofix Holdings, Inc. , Stryker Corporation, KLS martin and Medtronic, Zimmer Biomet Holdings, Inc., Evonik Industries AG and CAM Bioceramics BV. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Stratistics MRC We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. For more information, please visit http://www.strategymrc.com/


News Article | December 5, 2016
Site: www.newsmaker.com.au

According to Stratistics MRC, the Global Implantable Biomaterials market accounted for $84.4 billion in 2015 and is expected to reach $133.0 billion by 2022 growing at a CAGR of 6.7% from 2015 to 2022. Factors such as growing geriatric inhabitants worldwide, growing incidences of diseases and graft transplant surgeries, medical implants and technological advancements will drive the market growth. However, adverse reactions to biomaterials, strict regulatory requirements are some of the factors restraining the growth of global market. The cardiovascular segment is expected to account for the largest share among the applications. Metals constituted for the largest segment in 2015 and is growing at a strong CAGR during the forecast period. North America is expected to account for the largest share of the global biomaterials market, followed by Europe and Asia Pacific regions. Some of the key players in global Implantable Biomaterials market are AdvanSource Biomaterials Corporation, Collagen Matrix, Inc., Corbion Purac , Ceradyne, Inc, Celanese Corporation, Biomet, Inc., Evonik Industries AG, E. I. DU PONT DE Nemours And Company, Invibio, Inc., Orthofix Holdings, Inc. , Stryker Corporation, KLS martin and Medtronic, Zimmer Biomet Holdings, Inc., Evonik Industries AG and CAM Bioceramics BV. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK  o Spain      o Rest of Europe  • Asia Pacific o Japan        o China        o India        o Australia        o New Zealand       o Rest of Asia Pacific       • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements


Chuck C.J.,University of Bath | Davidson M.G.,University of Bath | Gobius Du Sart G.,Corbion Purac | Ivanova-Mitseva P.K.,University of Bath | And 2 more authors.
Inorganic Chemistry | Year: 2013

A series of N,N,N′,N′-tetrakis(2-hydroxyethyl)ethylenediamine (TOEEDH4) ligand precursors and their group 4 metal complexes have been prepared. The complexes have been characterized by single-crystal X-ray diffraction and 1H NMR spectroscopy, highlighting the ability to systematically vary the number of TOEED ligands within the system. Initial catalytic data for the solvent-free, ring-opening polymerization of rac-lactide (rac-LA), a promising degradable polymer produced from renewable resources, is reported. At 135 C, it has been demonstrated that the activity of the complexes is enhanced by increasing the number of labile isopropoxide groups. When the temperature was further increased to 165 C, all complexes demonstrated a far higher activity irrespective of the identity of the metal or number of labile initiator groups. Polymerization kinetics were monitored in real time using FT-IR spectroscopy with a diamond composite insertion probe and Ti 4(TOEED)(OiPr)12 was demonstrated to convert over 95% of the rac-LA within 160 min. © 2013 American Chemical Society.


Kuepper J.,RWTH Aachen | Ruijssenaars H.J.,Corbion Purac | Blank L.M.,RWTH Aachen | de Winde J.H.,Leiden University | Wierckx N.,RWTH Aachen
Journal of Biotechnology | Year: 2015

Pseudomonas putida S12 is a solvent-tolerant gamma-proteobacterium with an extensive track record for production of industrially relevant chemicals. Here we report the annotated complete genome sequence of this organism, including the megaplasmid pTTS12 which encodes many of the unique features of the S12 strain. © 2015 Elsevier B.V.


PubMed | Leiden University, Corbion Purac and RWTH Aachen
Type: | Journal: Journal of biotechnology | Year: 2015

Pseudomonas putida S12 is a solvent-tolerant gamma-proteobacterium with an extensive track record for production of industrially relevant chemicals. Here we report the annotated complete genome sequence of this organism, including the megaplasmid pTTS12 which encodes many of the unique features of the S12 strain.

Loading Corbion Purac collaborators
Loading Corbion Purac collaborators